| No. | Document Title | ID | Updated | Views |
|---|---|---|---|---|
| 121 | FDA Approval Date | 101806 | 2022-12-02 | 210 |
| 122 | IND/IDE Submit Date | 101805 | 2022-12-02 | 178 |
| 123 | Grantor | 101804 | 2022-12-02 | 169 |
| 124 | NCI/NIH Institution | 101803 | 2022-12-02 | 176 |
| 125 | Investigational Drug/Device | 101800 | 2022-12-02 | 177 |
| 126 | Fund Account No. | 101797 | 2022-11-29 | 236 |
| 127 | Sponsor Protocol No. | 101796 | 2022-11-29 | 175 |
| 128 | Sponsor Type | 101795 | 2022-11-29 | 227 |
| 129 | Staff: Stop Reason | 101793 | 2022-11-29 | 187 |
| 130 | Staff: Stop Date | 101792 | 2022-11-29 | 200 |
| 131 | Staff: Start Date | 101791 | 2022-11-29 | 193 |
| 132 | Protocol Staff Role | 70715 | 2022-11-29 | 281 |
| 133 | Managment Group | 101788 | 2022-11-29 | 227 |
| 134 | Toxicity Scheme | 24235 | 2022-11-25 | 272 |
| 135 | Pharmacy No. | 122680 | 2022-11-25 | 186 |
| 136 | IRB Committee | 101848 | 2022-11-17 | 161 |
| 137 | IRB: Submit Date | 101847 | 2022-11-17 | 194 |
| 138 | Subject MRN | 23831 | 2022-11-09 | 321 |
| 139 | Version Date | 99348 | 2022-10-05 | 199 |
| 140 | Verified By | 99349 | 2022-10-05 | 265 |
Not finding what you are looking for? Suggest a new document be created.